Is MDNA.TO undervalued or overvalued?

As of 2025-03-20, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.72 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.06 CAD, the upside of Medicenna Therapeutics Corp is -262.19%. This means that MDNA.TO is overvalued by 262.19%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-1.72 - -1.72	-1.72	-262.19%
DDM - Stable	(1.98) - (5.97)	(3.97)	-474.7%
DDM - Multi	(1.08) - (2.63)	(1.54)	-245.4%